RELATED ARTICLES

Share this article

Share

Mrs Ferguson, who was first diagnosed in 2007, continues to take curcumin without further treatment and her cancer cell count is negligible.

Her doctors, from Barts Health NHS Trust in London, wrote in the British Medical Journal Case Reports: ‘To the best of our knowledge, this is the first report in which curcumin has demonstrated an objective response in progressive disease in the absence of conventional treatment.’

The experts, led by Dr Abbas Zaidi, said some myeloma patients took dietary supplements alongside conventional treatment but ‘few, if any, use dietary supplementation as an alternative to standard antimyeloma therapy’.

Doctors say Dieneke Ferguson's case is the first recorded instance in which a patient has recovered by using turmeric (pictured) after stopping conventional medical treatments

Since the turn of the century, more than 50 studies have tested curcumin – the pigment in turmeric that gives it its bright yellow colour

Dieneke tried Curcumin, a component of turmeric, and five years on, her cancer cell count is negligible. Pictured: Dieneke Ferguson with the Olympics Torch in Brazil

But they added: ‘In the absence of further antimyeloma treatment the patient plateaued and has remained stable for the past five years with good quality of life.’

Since the turn of the century, more than 50 studies have tested curcumin – the pigment in turmeric that gives it that bright yellow colour.

A CENTURIES-OLD EASTERN REMEDY

Turmeric is a yellow spice widely used as a flavouring in the Indian subcontinent and as a food colouring by industry

It is ground from the dried root of an Asian plant called Curcuma longa and has been used in Eastern medicine for centuries

Studies have shown it is an effective painkiller and also reduces the risk of lung disease, Alzheimer’s, heart disease and depression

They suggest the spice can protect against several cancers, as well as Alzheimer’s, heart disease and depression.

It has also been shown to help speed recovery after surgery and effectively treat arthritis.

But although it is widely used in Eastern medicine, and has been studied for its anti-inflammatory and antiseptic effects, curcumin is not widely prescribed because it has never been tested in large-scale trials.

The doctors wrote that the ‘biological activity of curcumin is indeed remarkable’, including its ‘anti-proliferative effects in a wide variety of tumour cells’.

But Professor Jamie Cavenagh, one of the authors of the paper, stressed it may not work for all patients. He said: ‘A lot of my patients take curcumin at different stages of their treatment. I don’t object to it.

‘Dieneke’s is the best response I have observed and it is clear-cut because we had stopped all other treatment.’

Mrs Ferguson, who runs Hidden Art, a not-for-profit business helping artists market their work, is frustrated doctors cannot recommend the spice and wants more research carried out.

She said: ‘I hope my story will lead to more people finding out about the amazing health benefits of curcumin.’

Myeloma affects some 5,500 people in the UK every year, killing nearly 3,000.